| It is currently Wed May 22, 2013 7:37 pm |
|
All times are UTC - 8 hours [ DST ] |
|
Page 1 of 1 |
[ 2 posts ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| squiffy2 |
|
|||||
Joined: Wed Oct 14, 2009 3:00 pm Posts: 1686 |
|
|||||
| Top | |
|||||
| hwebb |
|
|||||
Joined: Thu Nov 26, 2009 4:00 pm Posts: 356 Location: Melbourne, Australia |
|
|||||
| Top | |
|||||
|
Page 1 of 1 |
[ 2 posts ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
| The changing demographic pattern of MS epidemiology | 0 | 700 | Wed Apr 28, 2010 2:35 am | ||
| A NEW TREATMENT IN IRAN WITH COMPLETE RECOVERY | 6 | 1056 | Fri May 17, 2013 9:30 pm | ||
| Study examines MS patients who restrict activity | 1 | 425 | Mon Mar 05, 2012 5:53 am | ||
| Study Suggests MS patients with cognitive problems.... | 0 | 374 | Thu Mar 07, 2013 5:07 am | ||
| Trophos launches first study of olesoxime in MS patients | 0 | 322 | Thu Mar 14, 2013 6:19 am | ||
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |